Avantor, Inc. Proceeds from Issuance or Sale of Equity
Avantor, Inc. (AVTR) reported Proceeds from Issuance or Sale of Equity of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2021-02-16
- Avantor, Inc. proceeds from issuance or sale of equity for the quarter ending 2020-12-31 was $0.00.
- Avantor, Inc. proceeds from issuance or sale of equity for the quarter ending 2020-09-30 was $0.00.
- Avantor, Inc. proceeds from issuance or sale of equity for the quarter ending 2019-12-31 was $0.00.
- Avantor, Inc. proceeds from issuance or sale of equity for the quarter ending 2019-09-30 was -$100.00K.
- Avantor, Inc. proceeds from issuance or sale of equity for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Avantor, Inc. proceeds from issuance or sale of equity for fiscal 2019 was $4.24B.
- Avantor, Inc. proceeds from issuance or sale of equity for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Avantor, Inc. proceeds from issuance or sale of equity for fiscal 2017 was $3.05B.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $0.00 derived: sum of 2 quarters · filed 2021-02-16 | $0.00 10-K · filed 2021-02-16 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $0.00 10-Q · filed 2020-10-27 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-29 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$100.00K derived: sum of 2 quarters · filed 2021-02-16 | $4.24B 10-K · filed 2021-02-16 | |
| 2019-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $4.24B 10-Q · filed 2020-10-27 | ||
| 2019-06-30 | $4.24B 10-Q · filed 2020-07-29 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $0.00 derived: sum of 2 quarters · filed 2021-02-16 | $0.00 10-K · filed 2021-02-16 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $3.05B 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |